Unknown

Dataset Information

0

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma.

ABSTRACT:

SUBMITTER: Bird S 

PROVIDER: S-EPMC8055205 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown CD19+ B Lymphocytes Are Predictive for Anti-Sars-Cov-2 Vaccination Response in Multiple Myeloma Patients
| S-EPMC8701540 | biostudies-literature
Unknown Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma.
| S-EPMC8711688 | biostudies-literature
Unknown Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
| S-EPMC8674107 | biostudies-literature
Unknown Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination.
| S-EPMC9471319 | biostudies-literature
Unknown Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma.
| S-EPMC8658197 | biostudies-literature
Unknown Markers of Antiviral Response in SLE Patients After Vaccination Against SARS-CoV-2.
| S-EPMC12563841 | biostudies-literature
Unknown Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib.
| S-EPMC8420430 | biostudies-literature
Unknown Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment.
| S-EPMC8345197 | biostudies-literature
Unknown Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients.
| S-EPMC9349960 | biostudies-literature
Unknown Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.
| S-EPMC9467550 | biostudies-literature